Ebpay生命医药出版社

Ebpay生命

100763

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

人成纤维细胞生长因子 9 顺利获得 TGF-β/BMP/Smad 信号通路诱导毛囊周期转换

 

Authors Zhang B , He X, Guo Y, Zhao S, Lan J, Chen F , Wan L, Tian H, Xu X

Received 20 December 2024

Accepted for publication 27 March 2025

Published 7 April 2025 Volume 2025:18 Pages 845—857

DOI http://doi.org/10.2147/CCID.S510057

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Michela Starace

Bowen Zhang,1,2 Xue He,1,2 Yaxin Guo,1,2 Shengnan Zhao,1,2 Jing Lan,1,2 Fuqiang Chen,1,2 Long Wan,3 Haishan Tian,4 Xuegang Xu1,2 

1Department of Dermatology, The First Hospital of China Medical University, Shenyang, People’s Republic of China; 2Key Laboratory of Immunodermatology, Ministry of Education and NHC; National joint Engineering Research Center for Theranostics of Immunological Skin Diseases, Shenyang, People’s Republic of China; 3Department of Pharmacy, The First Hospital of China Medical University, Shenyang, People’s Republic of China; 4School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, People’s Republic of China

Correspondence: Xuegang Xu, Department of Dermatology, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, People’s Republic of China, Email xuxuegang2749290@163.com

Background: Fibroblast growth factor 9 (FGF9) is a crucial regulator of hair follicle development; however, the precise regulatory role of FGF9 on the biological behavior of hair follicles remains unclear.
Purpose: Explore the effects of recombinant human fibroblast growth factor (rhFGF9) on hair follicle growth and cycle transition in mice, as well as the associated mechanisms.
Methods: We utilized soluble recombinant human fibroblast growth factor 9 (rhFGF9), expressed in Escherichia coli, and injected it into the dorsal skin of mice. RNA sequencing (RNA-seq) was employed to identify differentially expressed genes and associated key metabolic pathways in skin tissue. Additionally, immunohistochemistry, quantitative PCR (qPCR), and Western blotting techniques were applied to assess the expression of factors related to metabolic pathways across different groups.
Results: RhFGF9 stimulated hair growth by inducing the anagen phase in C57BL/6 N mice. Histological analysis revealed that intradermal injections of rhFGF9 enhanced hair follicle development. Transcriptomic analysis revealed that the mechanism underlying this effect might involve the transforming growth factor-β (TGF-β) signaling pathway. Immunohistochemistry, quantitative PCR, and Western blot analyses further demonstrated the upregulation of TGF-β 2, TGF-β 3, bone morphogenetic protein 4 (BMP4), and pSmad2 expression in the experimental group.
Conclusion: These results indicate that rhFGF9 might promote hair growth via the TGF-β/BMP/Smad signaling pathway and highlight its potential as a therapeutic option for treating hair loss.

Keywords: fibroblast growth factor 9, hair growth, hair follicle, TGF-β/BMP/Smad pathway

Download Article[PDF]